News Focus
News Focus
icon url

Bill_ENG

05/25/21 2:51 PM

#167732 RE: misiu143 #167724

He is not mistaken, that is the treatment protocol for the 594 patient moderate trial.

Yup, they are doing a phase 3 that follows the patient population that benefitted most in CD10.

NP covering all bases.

Lot of potential here.